| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silo Pharma, Inc. | Director | Options (right to buy) | 50,000 | 23 May 2025 | Direct | ||
| Hoth Therapeutics, Inc. | Director | Options | 25,000 | 19 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SILO | Silo Pharma, Inc. | 23 May 2025 | 1 | $0 | 4 | Director | 27 May 2025, 19:00 |
| HOTH | Hoth Therapeutics, Inc. | 19 Aug 2024 | 1 | $0 | 4 | Director | 21 Aug 2024, 16:15 |
| HOTH | Hoth Therapeutics, Inc. | 05 Jan 2024 | 1 | $0 | 4 | Director | 08 Jan 2024, 17:01 |
| HOTH | Hoth Therapeutics, Inc. | 17 Jul 2023 | 1 | $0 | 4 | Director | 18 Jul 2023, 16:15 |
| HOTH | Hoth Therapeutics, Inc. | 13 Dec 2022 | 1 | $0 | 4 | Director | 13 Dec 2022, 15:40 |
| HOTH | Hoth Therapeutics, Inc. | 07 Dec 2022 | 0 | $0 | 3 | Director | 13 Dec 2022, 15:35 |
| SILO | Silo Pharma, Inc. | 27 Sep 2022 | 0 | $0 | 3 | Director | 04 Oct 2022, 21:18 |